View in EDS PDF Full Text

Hacia el futuro de la cirugía: Análisis descriptivo de la implementación del primer centro de cirugía robótica en un hospital público nacional.

Saved in:
Bibliographic Details
Title: Hacia el futuro de la cirugía: Análisis descriptivo de la implementación del primer centro de cirugía robótica en un hospital público nacional.
Alternate Title: Towards the future of surgery: Descriptive analysis of the implementation of the first robotic surgery center in a national public hospital.
Authors: Larenas Huguet, Francisca1 flarenas@uchile.cl, Acuña Acuña, Bruno1, López, Miguel1, Segovia, Sofía1, Sánchez, Catherine1, Fullá, Juan1
Source: Revista de Cirugia. 2025, Vol. 77 Issue 1, p12-20. 9p.
Abstract (English): Objective: San Borja Arriarán Clinical Hospital (HCSBA) was the first public hospital in Chile to adopt the Da Vinci® robotic surgery system. This study aims to characterize the treated population, describe the clinical outcomes of the surgeries, and analyze their costs. Materials and Methods: A descriptive database including clinical and economic variables of all robotic surgeries performed between October 2022 and October 2023 across 7 surgical specialties was analyzed. Quantitative variables were described using mean and standard deviation, and qualitative variables through frequencies and percentages. Results: A total of 186 surgeries were analyzed, involving patients with an average age of 57.98 (SD: 20.31) years. At least one comorbidity was observed in 74.19% of patients, with hypertension and type 2 diabetes mellitus being the most frequent. Cardiac surgeries exhibited the highest percentage of intra (29%) and postoperative (43%) complications, the highest volume of intraoperative bleeding (971 ml, SD: 690.6), the longest duration (180.57 min, SD: 56.9), more days of hospitalization (8.29 days, SD: 2.3), and more days of medical leave (25 days, SD: 3.3). The average cost of surgeries ranged from $2.9 to $4.7 million Chilean pesos (CLP), with cardiac and urological surgeries being the most expensive (average of $4.7 and $3.7 million CLP, respectively). Discussion and Conclusion: The implementation and use of robotic surgery in HCSBA could reduce costs at various levels, thus cost-effectiveness studies are required to compare robotic surgery with other techniques. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): Objetivo: El Hospital Clínico San Borja Arriarán (HCSBA) es el primer hospital público en Chile en adoptar el sistema de cirugía robótica Da Vinci®. Este estudio busca caracterizar la población atendida, describir los resultados clínicos de las cirugías y analizar sus costos. Materiales y Métodos: Se analizó una base de datos descriptiva incluyendo variables clínicas y económicas de todas las cirugías robóticas realizadas entre octubre de 2022 y octubre de 2023 en 7 especialidades quirúrgicas. Se describieron variables cuantitativas mediante media y desviación estándar y variables cualitativas mediante frecuencias y porcentajes. Resultados: Se analizaron 186 cirugías de pacientes con edad promedio de 57,98 (DE: 20,31) años. Se observó al menos una comorbilidad en el 74,19% de los pacientes, destacando como las más frecuentes la hipertensión arterial y la diabetes mellitus tipo 2. Las cirugías cardiacas mostraron el mayor porcentaje de complicaciones intra (29%) y postoperatorias (43%), el mayor volumen de sangrado intraoperatorio (971 ml, DE: 690,6), la mayor duración (180,57 min, DE: 56,9), más días de hospitalización (8,29 días, DE: 2,3) y más días de licencia médica (25 días, DE: 3,3). El costo promedio de las cirugías osciló entre $2,9 y $4,7 millones de pesos chilenos (CLP), siendo las cardíacas y urológicas las más costosas (promedio CLP $4,7 y $3,7 millones, respectivamente). Discusión y Conclusión: La implementación y uso de la cirugía robótica en HCSBA ha sido factible. Se podría reducir costos a varios niveles, por lo que se requieren estudios de costo-efectividad, que permita comparar la cirugía robótica con otras técnicas. [ABSTRACT FROM AUTHOR]
Copyright of Revista de Cirugia is the property of Sociedad de Cirujanos de Chile and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:Objective: San Borja Arriarán Clinical Hospital (HCSBA) was the first public hospital in Chile to adopt the Da Vinci® robotic surgery system. This study aims to characterize the treated population, describe the clinical outcomes of the surgeries, and analyze their costs. Materials and Methods: A descriptive database including clinical and economic variables of all robotic surgeries performed between October 2022 and October 2023 across 7 surgical specialties was analyzed. Quantitative variables were described using mean and standard deviation, and qualitative variables through frequencies and percentages. Results: A total of 186 surgeries were analyzed, involving patients with an average age of 57.98 (SD: 20.31) years. At least one comorbidity was observed in 74.19% of patients, with hypertension and type 2 diabetes mellitus being the most frequent. Cardiac surgeries exhibited the highest percentage of intra (29%) and postoperative (43%) complications, the highest volume of intraoperative bleeding (971 ml, SD: 690.6), the longest duration (180.57 min, SD: 56.9), more days of hospitalization (8.29 days, SD: 2.3), and more days of medical leave (25 days, SD: 3.3). The average cost of surgeries ranged from $2.9 to $4.7 million Chilean pesos (CLP), with cardiac and urological surgeries being the most expensive (average of $4.7 and $3.7 million CLP, respectively). Discussion and Conclusion: The implementation and use of robotic surgery in HCSBA could reduce costs at various levels, thus cost-effectiveness studies are required to compare robotic surgery with other techniques. [ABSTRACT FROM AUTHOR]
ISSN:24524557
DOI:10.35687/s2452-454920250012339